📰 Nasdaq Aadi News
Nasdaq Aadi News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Aadi. Real-time updates on events, politics, business and more.
May 18, 2024
HC Wainwright reaffirmed their neutral rating on shares of Aadi Bioscience (NASDAQ:AADI – Free Report) in a research report released on Tuesday morning, Benzinga reports. HC Wainwright also issued estimates for Aadi Bioscience’s Q2 2024 earnings at ($0.66) EPS, Q4 2024 earnings at ($0.71) EPS, FY2024 earnings at ($2.73) EPS, Q1 2025 earnings at ($0.73) […]
May 2, 2024
Aadi Bioscience (NASDAQ:AADI – Get Free Report) is scheduled to be posting its quarterly earnings results before the market opens on Wednesday, May 8th. Analysts expect Aadi Bioscience to post earnings of ($0.66) per share for the quarter. Aadi Bioscience (NASDAQ:AADI – Get Free Report) last posted its quarterly earnings results on Wednesday, March 13th. […]
May 2, 2024
Aadi Bioscience (NASDAQ:AADI – Get Free Report) is set to issue its quarterly earnings data before the market opens on Wednesday, May 8th. Analysts expect the company to announce earnings of ($0.66) per share for the quarter. Aadi Bioscience (NASDAQ:AADI – Get Free Report) last posted its quarterly earnings data on Wednesday, March 13th. The […]
April 23, 2024
Aadi Bioscience (NASDAQ:AADI – Get Free Report) and Statera Biopharma (NASDAQ:STAB – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, dividends and earnings. Profitability This table compares Aadi Bioscience and […]
February 3, 2024
Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) Chairman Neil Desai sold 42,000 shares of the company’s stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $1.74, for a total value of $73,080.00. Following the completion of the sale, the chairman now owns 1,453,543 shares […]
December 19, 2023
Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) was the recipient of a large growth in short interest in November. As of November 30th, there was short interest totalling 789,000 shares, a growth of 6.1% from the November 15th total of 743,700 shares. Currently, 4.6% of the company’s stock are sold short. Based on an […]
December 8, 2023
Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) Chairman Neil Desai sold 7,037 shares of the stock in a transaction that occurred on Wednesday, December 6th. The shares were sold at an average price of $4.82, for a total value of $33,918.34. Following the sale, the chairman now owns 1,537,543 shares of the company’s stock, […]
December 8, 2023
Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) Chairman Neil Desai sold 7,037 shares of the stock in a transaction on Wednesday, December 6th. The shares were sold at an average price of $4.82, for a total value of $33,918.34. Following the completion of the sale, the chairman now owns 1,537,543 shares in the company, […]
December 6, 2023
Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) Chairman Neil Desai sold 8,347 shares of the business’s stock in a transaction dated Friday, December 1st. The stock was sold at an average price of $5.14, for a total transaction of $42,903.58. Following the completion of the sale, the chairman now owns 1,571,196 shares in the […]
November 3, 2023
Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) Chairman Neil Desai sold 10,338 shares of the business’s stock in a transaction dated Wednesday, November 1st. The shares were sold at an average price of $4.32, for a total transaction of $44,660.16. Following the completion of the transaction, the chairman now owns 1,611,205 shares in the […]